Expert faculty will discuss the safety and efficacy of currently available antipsychotic agents, strategies for individualizing treatment and monitoring symptoms, and the role of long-acting injectables for promoting medication adherence.
Explain the latest advances in our understanding of binge eating disorders. Discuss current and emerging therapies for binge eating disorder. Recognize the role of evidence-based psychotherapy as an adjunct.
“Fighting the Uphill Battle: Current Evidence in Obesity Management” will provide clinicians with the latest evidence regarding obesity management in a form that can be readily integrated into practice. Clinicians will also receive real-world strategies for effectively addressing weight with their patients and initiating conversations that can begin to reverse the obesity trend that pervades society.
Management strategies for cardiovascular risk in patients with type 2 diabetes (T2D) are rapidly evolving as cardiovascular outcome trial (CVOT) data with newer glucose-lowering therapies continues to emerge
Immuno-oncology for bladder cancer has been around for more than four decades in the form of BCG intravesical therapy for NMIBC. For more advanced disease, systemic platinum-based chemotherapy has been the standard first-line treatment.